
Agilent Technologies Inc
Life Sciences Tools & Services
Agilent Technologies Inc (A) Stock News
The latest A headlines and market coverage — 30 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Compass, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - COMP
Rosen Law Firm has filed a class action lawsuit on behalf of former Anywhere Real Estate shareholders who received Compass, Inc. stock in a January 9, 2026 merger. The lawsuit alleges that merger offering materials misrepresented regulatory compliance efforts and omitted material information about defendants' undisclosed hiring of Trump-connected lobbyists and lawyers to obtain backdoor access to DOJ officials to circumvent standard merger review processes. The complaint claims these practices contradicted attestations of 'reasonable best efforts' for regulatory approval and allowed the merger to close despite anticompetitive effects. The deadline to serve as lead plaintiff is December 8, 2026.
- GlobeNewswire Inc.·
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Millrose Properties, Inc. (MRP)
A securities class action lawsuit has been filed against Millrose Properties, Inc. for allegedly failing to disclose that it purchased $200 million in finished homes from parent company Lennar and leased them at a loss, contrary to stated business objectives. The disclosure by Hunterbrook Media on October 2, 2026 caused Millrose's stock to fall 8.5%, dropping from $24.61 to $22.51.
- GlobeNewswire Inc.·
MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)
MannKind Corporation announced new clinical data for Furoscix ReadyFlow, an autoinjector delivering IV-equivalent diuretic therapy for heart failure and chronic kidney disease. Presented at the HFSA 2026 Annual Scientific Meeting, the data demonstrates comparable urine output to IV furosemide, consistent bioavailability across injection sites, and seamless transition capabilities from the previous On-body Infusor formulation. The product received FDA approval in July 2026 and is designed to enable earlier outpatient intervention for fluid overload management.
- GlobeNewswire Inc.·
Brookfield Infrastructure Corporation Announces New Date for Meeting on Proposed Corporate Simplification
Brookfield Infrastructure Corporation (BIPC) has rescheduled its shareholder meeting to October 29, 2026, to allow additional time for voting on a proposed corporate simplification. The plan would combine Brookfield Infrastructure Partners L.P. (BIP) and BIPC into a single publicly traded corporation called Brookfield Infrastructure Partners Inc. (BIP Inc.). Votes received to date show strong support, and both company boards unanimously recommend approval. The simplification is expected to be tax-deferred and completed in Q4 2026 if approved.
- GlobeNewswire Inc.·
Coastal Community Bank Invests in Workforce Housing Through Koz Development's PNW Attainable Workforce Housing Fund
Coastal Community Bank announced its investment in Koz Development's PNW Attainable Workforce Housing Fund, which aims to expand high-quality, environmentally responsible housing for working individuals and families across Washington and Oregon. The fund targets the 'missing middle'—households earning too much for traditional assistance but struggling with market-rate housing affordability. In Washington, the investment also supports Koz developments in the Ballmer Group's Washington Family Housing Fund partnership.
- GlobeNewswire Inc.·
Brookfield Infrastructure Corporation Announces New Date for Meeting on Proposed Corporate Simplification
Brookfield Infrastructure Corporation (BIPC) has rescheduled its shareholder meeting to October 29, 2026, to allow additional time for voting on a proposed corporate simplification. The plan would combine Brookfield Infrastructure Partners L.P. (BIP) and BIPC into a single publicly traded corporation called Brookfield Infrastructure Partners Inc. (BIP Inc.). Votes received to date show strong support, and both company boards unanimously recommend approval. The simplification is expected to be tax-deferred and completed in Q4 2026 if approved.
- GlobeNewswire Inc.·
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Coastal Financial Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CCB
Rosen Law Firm has filed a class action lawsuit against Coastal Financial Corporation (CCB) on behalf of investors who purchased common stock between October 28, 2024 and July 29, 2026. The lawsuit alleges that defendants misrepresented and failed to disclose key facts concerning credit risks associated with Coastal Financial's CCBX business, including exposure to credit losses and the effectiveness of contractual indemnification protections. Investors who wish to serve as lead plaintiff must move the Court by December 1, 2026.
- GlobeNewswire Inc.·
Brookfield Renewable Partners Announces New Date for Meeting on Proposed Corporate Simplification
Brookfield Renewable Partners announced the rescheduling of its special unitholders' meeting to October 29, 2026, to achieve the required two-thirds voting threshold for its proposed corporate structure simplification. The merger would combine BEP and BEPC into a single publicly traded corporation, with over 99.7% of votes cast so far in favor. The simplification is expected to be tax-deferred and completed in Q4 2026, pending regulatory approvals.
- GlobeNewswire Inc.·
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG
Rosen Law Firm has filed a class action lawsuit against Alphabet Inc. on behalf of investors who purchased securities between May 19, 2026 and July 16, 2026. The lawsuit alleges that Alphabet made materially false and misleading statements regarding the Gemini 3.5 Pro, claiming it delivered disappointing training results and would face significant launch delays. Investors who purchased during this period may be eligible for compensation. The deadline to serve as lead plaintiff is December 1, 2026.
- GlobeNewswire Inc.·
HDB 4-DAY DEADLINE ALERT: HDFC Bank Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 13, 2026 Lead Plaintiff Deadline - HBSS
HDFC Bank Limited faces a securities fraud class action lawsuit alleging that senior management concealed a covert scheme involving approximately Rs 45 crore ($4.7 million USD) in disguised payments to Maharashtra State Road Development Corporation to induce deposits. The scheme involved routing above-market interest rate differentials through the marketing department as fake sponsorship contributions, violating RBI regulations and internal anti-corruption policies. The fraud allegedly surfaced in March 2026 with the resignation of the Chairman citing ethical concerns, followed by a May 2026 investigative report exposing the scheme. Investors who purchased HDFC securities between July 17, 2023, and May 26, 2026, have until October 13, 2026, to apply as lead plaintiffs.
- GlobeNewswire Inc.·
INV INVESTOR ALERT: Innventure, Inc. Investors with Substantial Losses Have Opportunity to Lead the INNVENTURE Securities Fraud Class Action - HBSS
Innventure, Inc. (NASDAQ: INV) faces a securities class action lawsuit after its stock price crashed 55% on August 14, 2026, following the company's removal of the DarkNX project from its 2026 forecast and suspension of revenue guidance. Forensic research firm Morpheus Research published a report claiming the 300MW data center project with DarkNX was non-existent, with former executives allegedly using 'false information' and 'pure fiction' for revenue projections. The company later confirmed the deployment site was no longer available, leading to a 74% stock decline between May 27 and August 14, 2026.
- GlobeNewswire Inc.·
AARD 4-DAY DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 13, 2026 Lead Plaintiff Deadline - HBSS
Hagens Berman announces a securities class action lawsuit against Aardvark Therapeutics for allegedly making materially false statements about ARD-101's safety. The company failed to disclose cardiac observations during trials, leading to a voluntary pause of the Phase 3 HERO trial in February 2026 (56% stock decline) and an FDA clinical hold in May 2026 (32.1% additional decline). Investors with substantial losses have until October 13, 2026, to become lead plaintiffs.
- GlobeNewswire Inc.·
Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower - HBSS
Hims & Hers Health (NYSE: HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company deceptively shared consumers' health data with third-party advertising platforms like Meta and Snap, and violated billing regulations by charging for prescriptions before medical consultations. The stock plunged 14.7% on July 29, 2026, erasing over $970 million in market value.
- GlobeNewswire Inc.·
UWMC INVESTOR ALERT: UWM Holdings Corporation Investors with $150K+ Losses Have Opportunity to Lead UWM Class Action Lawsuit - HBSS
UWM Holdings Corporation is facing a securities class action lawsuit after its stock plummeted 34% on August 6, 2026, following disclosure of a $603 million hedging loss related to its failed acquisition of Two Harbors Investment Corp. The company allegedly over-hedged its position and failed to adequately disclose the risks to investors. UWM's equity plunged 38% sequentially, and the company announced a dilutive recapitalization plan. The stock has declined approximately 75% since the acquisition announcement in December 2025.
- GlobeNewswire Inc.·
BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - HBSS
Beta Bionics (NASDAQ: BBNX) faces a securities class action lawsuit for allegedly misleading investors about its iLet automated insulin delivery system. The company concealed thousands of safety complaints, including life-threatening hypoglycemic events, and failed to report them to the FDA as required. An FDA warning letter in February 2026 revealed the violations, causing significant shareholder losses during the class period of July 30, 2025 to February 24, 2026.
- GlobeNewswire Inc.·
Better Home & Finance (BETR) Faces Securities Class Action Amid 75% Sequential Increase in Net Loss, Dimmed Loan Volume Prospects - HBSS
Better Home & Finance faces a securities class action lawsuit after reporting a 75% sequential increase in net loss for Q1 2026 and drastically missing its $1 billion monthly loan volume target, now projecting only $550 million per month. The company's stock plunged 28% on May 7, 2026, after management's prior assurances about reaching the $1 billion target proved unfounded. The lawsuit alleges the company failed to disclose that conversion rates were slowing due to macroeconomic factors.
- GlobeNewswire Inc.·Neutral
MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure
MindWave Innovations Inc. USA, a subsidiary of Apimeds Pharmaceuticals US, Inc., signed three blockchain network agreements within 10 days with AQUAE Holdings (climate finance), Flash Sports & Media Holdings (sports media), and BlockAssure Inc. (insurance). Each agreement follows the same model where MindWave builds and operates dedicated MindChain networks while receiving 20% token/credit allocations. However, the parent company disclosed substantial doubt about its ability to continue as a going concern.
- GlobeNewswire Inc.·
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Papa John’s International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PZZA
Rosen Law Firm is reminding investors who purchased Papa John's International common stock between August 7, 2025 and August 5, 2026 of the November 2, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Papa John's made materially false and misleading statements about its transformation efforts, which were taking longer than expected and failed to prevent market share losses, ultimately requiring a shift toward increased promotional efforts.
- GlobeNewswire Inc.·
DAVA INVESTOR ALERT: Endava plc Investors with Substantial Losses Have Opportunity to Lead the Endava Class Action Lawsuit - HBSS
Endava plc (NYSE: DAVA) is facing a securities class action lawsuit after its stock plummeted 25% on September 22, 2026, following disclosure of serious management and accounting problems. The company placed its CFO on administrative leave and announced delays in financial reporting due to an internal investigation into accounting treatment of customer and supplier agreements. Investors with substantial losses are urged to contact Hagens Berman by the November 30, 2026 lead plaintiff deadline.
- GlobeNewswire Inc.·
Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against Azenta, Inc. following allegations of materially misleading business information. The investigation was prompted by CEO John P. Marotta's resignation on August 22, 2026, which triggered a 12% stock decline on August 24, 2026. The firm is preparing a class action lawsuit to recover investor losses.
- The Motley Fool·
Netflix Is Reportedly Cutting 5% of Its Staff. Its 2022 Layoffs Came Days After the Stock Bottomed.
Netflix is reportedly planning to cut around 5% of its ~16,000-person workforce (approximately 800 jobs) as early as next week. The layoffs aim to align non-content spending growth with slowing revenue growth. Unlike the 2022 layoffs that coincided with a stock bottom, the current situation differs: Netflix maintains double-digit revenue growth and a 33.4% operating margin, suggesting this is a margin optimization move rather than a defensive measure. The stock trades at 19x forward earnings, with revenue growth cooling from 18% to 13% year-over-year.
- The Motley Fool·
Stock Market Today, Oct. 9: AT&T Slides on SpaceX Spectrum Deal Threat
SpaceX's acquisition of 800 MHz low-band spectrum triggered a sharp selloff in legacy wireless carriers on October 9, 2026. AT&T dropped 9.81%, Verizon fell 8.75%, and T-Mobile declined 13.27% as investors worried about increased competition and the erosion of the telecom oligopoly. However, analysts note AT&T's strong dividend yield (5%) and fiber infrastructure may provide some downside protection.
- The Motley Fool·
Stock Market Today, Oct. 9: PG&E Gains on Earnings Call Anticipation Before October 22 Update
PG&E stock rose 3.63% to $13.13 on October 9, 2026, as investors anticipate its October 22 earnings call and wildfire-liability commentary. Despite the gain, PG&E shares remain down 17% over the past year due to wildfire liability concerns from Los Angeles fires and delayed state legislative action on utility liability protection. However, the company may benefit from increased electricity demand driven by the AI boom and California's data center growth.
- Zacks Investment Research·
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
DaVita HealthCare (DVA) closed at $179.25, up 1.26% and outperforming the S&P 500. The kidney dialysis provider is projected to report 50.6% EPS growth and 3.23% revenue growth in the upcoming quarter, with full-year estimates showing 35.16% earnings growth. Trading at a Forward P/E of 12.15 (below industry average of 20.06) and a PEG ratio of 0.46, DVA holds a Zacks Rank #3 (Hold) rating.
- Zacks Investment Research·Neutral
Star Bulk Carriers (SBLK) Stock Falls Amid Market Uptick: What Investors Need to Know
Star Bulk Carriers (SBLK) declined 2.53% to $29.70, underperforming the broader market which gained 0.6-0.83%. Despite the stock's recent weakness, analysts expect strong earnings growth of 375% year-over-year with revenue projected to rise 49.94%. The company holds a Zacks Rank #3 (Hold) with a Forward P/E of 6.73, trading at a discount to its industry average.
- Zacks Investment Research·
AST SpaceMobile, Inc. (ASTS) Stock Sinks As Market Gains: Here's Why
AST SpaceMobile (ASTS) closed down 10.55%, underperforming the broader market. The company holds a Zacks Rank #4 (Sell) rating with expected EPS of -$0.39 for the upcoming quarter, though revenue is projected to grow 206.56% year-over-year to $45.19 million. The Wireless Equipment industry ranks in the bottom 29% of all industries.
- Zacks Investment Research·Neutral
Paccar (PCAR) Stock Sinks As Market Gains: Here's Why
Paccar (PCAR) closed down 1.48% to $108.04, underperforming the S&P 500's 0.6% gain. The truck maker has lost 10.53% over the past month but maintains a Zacks Rank #2 (Buy) rating. Analysts expect strong Q3 earnings of $1.61 EPS (up 43.75% YoY) and full-year revenue of $28.61 billion (up 9.05% YoY), though the stock trades at a premium valuation with a Forward P/E of 18.57 versus the industry average of 16.06.
- Zacks Investment Research·
Kyndryl Holdings, Inc. (KD) Stock Falls Amid Market Uptick: What Investors Need to Know
Kyndryl Holdings (KD) declined 1.09% to $11.75 while broader markets gained, falling 6.31% over the past month. The company is expected to report lower EPS and revenue for the upcoming quarter, though full-year earnings are projected to grow 26.71%. With a Zacks Rank of #3 (Hold) and a Forward P/E of 6.43 (below industry average of 15.81), the stock trades at a valuation discount despite operating in a weak industry ranked in the bottom 31%.
- Zacks Investment Research·
BigBear.ai Holdings, Inc. (BBAI) Stock Slides as Market Rises: Facts to Know Before You Trade
BigBear.ai Holdings (BBAI) declined 1.24% to $2.39, underperforming the broader market which gained 0.6-0.83%. The stock has fallen 14.18% over the past month, lagging the Computer and Technology sector's 4.03% gain. Analysts expect the company to report earnings of -$0.05 per share with 15% revenue growth to $38.11 million. BBAI currently holds a Zacks Rank #3 (Hold) rating with no recent changes to EPS estimates.
- Zacks Investment Research·
Why AppFolio (APPF) Outpaced the Stock Market Today
AppFolio (APPF) closed at $202.20, up 2.4% on the day, outperforming the S&P 500's 0.6% gain. However, the stock has declined 4.04% over the past month. The company is expected to report Q3 2026 earnings on October 22 with projected EPS of $1.77 (up 35.11% YoY) and revenue of $293.84 million (up 17.84% YoY). AppFolio holds a Zacks Rank #2 (Buy) rating but trades at a premium valuation with a Forward P/E of 28.62 versus its industry average of 20.7.